Modern Biosciences Ltd.
- Country
- 🇬🇧United Kingdom
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- -
Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects
- Conditions
- Pharmacokinetics
- Interventions
- First Posted Date
- 2024-04-23
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Modern Biosciences Ltd
- Target Recruit Count
- 48
- Registration Number
- NCT06379958
- Locations
- 🇬🇧
Celerion, Belfast, United Kingdom
A Study to Investigate Leramistat in Patients With IPF
- First Posted Date
- 2023-07-19
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Modern Biosciences Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT05951296
- Locations
- 🇺🇸
UCSF Fresno, Fresno, California, United States
🇺🇸National Jewish Health Main Campus, Denver, Colorado, United States
🇺🇸MedStar Georgetown University Hospital, Washington, District of Columbia, United States
Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: PlaceboDrug: MBS2320 5 mgDrug: MBS2320 20 mgDrug: MBS2320 40 mg
- First Posted Date
- 2022-07-15
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Modern Biosciences Ltd
- Target Recruit Count
- 248
- Registration Number
- NCT05460832
- Locations
- 🇧🇦
Site 1201 - Univerzitetski Klinicki Centar Republike Srpske, Banja Luka, Bosnia and Herzegovina
🇧🇦Site 1204 - Univerzitetski Klinicki Centar Republike Srpske, Banja Luka, Bosnia and Herzegovina
🇧🇦Site 1202 - General Hospital Gradiška, Gradiška, Bosnia and Herzegovina
Safety, Tolerability and Efficacy of MBS2320 in Patients With Rheumatoid Arthritis
- First Posted Date
- 2017-05-03
- Last Posted Date
- 2019-08-14
- Lead Sponsor
- Modern Biosciences Ltd
- Target Recruit Count
- 121
- Registration Number
- NCT03139136
- Locations
- 🇷🇴
Arensia, Bucharest, Romania
Safety and Tolerability Study of MBS2320 in Healthy Subjects and Subjects With Rheumatoid Arthritis
- Conditions
- Arthritis, Rheumatoid
- Interventions
- First Posted Date
- 2015-06-25
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Modern Biosciences Ltd
- Target Recruit Count
- 105
- Registration Number
- NCT02480946
- Locations
- 🇬🇧
Covance Royal Liverpool Clinical Research Unit,Royal Liverpool University Hospital, Liverpool, Merseyside, United Kingdom
🇬🇧Covance Clinical Research Unit Ltd., Leeds, West Yorkshire, United Kingdom
🇬🇧NIHR/Wellcome Trust Imperial Clinical Research Facility (CRF), London, United Kingdom